For more than two decades, international cooperation and information technology have been playing key roles in the identification of suitable unrelated donors and cord blood units for hematopoietic SCT. To ensure consistent coding and interpretation of HLA data among the linked computer systems, the World Marrow Donor Association has standardized the extensions of the World Health Organization (WHO) Nomenclature for factors of the HLA system applied in practice. The first version of this report published in 2007 has become the reference for the technical validation of HLA information on donors and patients in the context of search and matching and is used by registries of volunteer unrelated hematopoietic stem cell donors and umbilical cord blood banks throughout the world. The present update became necessary after the major revision of the WHO HLA nomenclature in April 2010. It now covers issues arising when alleles are withdrawn or renamed because of the continuous updating of the WHO HLA nomenclature. In addition, formal validation and interpretation rules for the so-called 'multiple allele codes' have been added.
INTRODUCTION
The annual reports of the World Marrow Donor Association (WMDA) demonstrate the continuing importance of international cooperation in the search for unrelated hematopoietic stem cell donors. 1 In 2011, almost half of the 14 209 products provided for transplantation crossed a country border to reach the recipient. Often, identification of suitable unrelated donors or cord blood units (hereafter, 'donors') is a complex, usually iterative process typically requiring extensive bidirectional communication between the transplant center or search unit and national and/or international donor registries, donor centers or cord blood banks (hereafter, 'registry'). 2, 3 In this context, the development and establishment of communication networks like the European Marrow Donor Information System is of major importance. 4, 5 This peer-to-peer network currently connects 30 international registriesrepresenting 490% of the global pool of unrelated donorsautomating their interactions in the search process. In addition, Bone Marrow Donors Worldwide maintains a comprehensive database of the HLA phenotypes of their affiliated registries, offering an online access for quick identification of registries with potentially matching donors for any given patient. 6 Both initiatives rely on standards ensuring that the sender and receiver of any HLArelated information apply the same rules for data validation and interpretation. These were compiled by the Information Technology Working Group of the WMDA and first published as 'WMDA HLA Nomenclature Guidelines' in 2007. 2 All related nomenclature and technical information have since been continuously updated on two WMDA-approved reference web sites. 7, 8 UPDATE TO THE WMDA HLA NOMENCLATURE GUIDELINES An update to these standards became necessary because of the major revision of the World Health Organization (WHO) HLA nomenclature in April 2010. 9, 10 Moreover, other issues seriously hampering the smooth electronic exchange of HLA-typing data were addressed. The updated version of the WMDA HLA Nomenclature Guidelines was approved by the WMDA Board in May 2012. The entire document is available as supplementary information to this publication.
Modifications following the 2010 revision of the WHO HLA nomenclature The 2010 update of the WHO HLA nomenclature introduced colons to separate the logical segments of allele designations removing the two-digit limit for each information unit in order to assign names to pending new alleles. At the same time, systematic naming workarounds and deficits concerning the loci HLA-A, -B and -DPB1 were fixed (for example, removal of 'rollover' allele groups A*92 and B*95), leading to an extensive renaming of alleles. Moreover, new group codes were introduced representing all expressed alleles leading to identical protein sequences (P suffix after two fields) or alleles with identical nucleotide sequences (G suffix after three fields) in the exon(s) encoding the Ag-recognition site. 9, 10 This update takes into account all the above changes and extensions leading to modifications throughout the guideline document. The Information Technology Working Group is continuously monitoring and vetting new approaches for capturing genetic data in a more primary format that is not impacted by nomenclature changes and deals with HLA ambiguity in ways that are more generic, open and rule-driven. [13] [14] [15] 
